> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Correvio Atrial Fibrillation Drug
- URL: https://www.fdaweb.com/panel-to-review-correvio-atrial-fibrillation-drug/
- Published: 2019-11-01T12:00:00.000Z
- Updated: 2026-09-14T15:51:32.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145399

*Federal Register* notice: FDA has announced a 12/10 Cardiovascular and Renal Drugs Advisory Committee meeting. Panel members are scheduled to discuss a Correvio International NDA for vernakalant HCl solution for the proposed indication of rapid conversion of recent onset atrial fibrillation to sinus rhythm for non-surgery patients. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-23978.pdf?ref=fdaweb.com).